116 related articles for article (PubMed ID: 9493976)
21. Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy.
Cho-Chung YS; Nesterova M; Becker KG; Srivastava R; Park YG; Lee YN; Cho YS; Kim MK; Neary C; Cheadle C
Ann N Y Acad Sci; 2002 Jun; 968():22-36. PubMed ID: 12119265
[TBL] [Abstract][Full Text] [Related]
22. Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression.
Willets JM; Parent JL; Benovic JL; Kelly E
J Neurochem; 1999 Nov; 73(5):1781-9. PubMed ID: 10537035
[TBL] [Abstract][Full Text] [Related]
23. Antisense targeting protein kinase A type I as a drug for integrated strategies of cancer therapy.
Tortora G; Ciardiello F
Ann N Y Acad Sci; 2003 Dec; 1002():236-43. PubMed ID: 14751838
[TBL] [Abstract][Full Text] [Related]
24. Expression and action of transforming growth factor alpha in normal ovarian surface epithelium and ovarian cancer.
Doraiswamy V; Parrott JA; Skinner MK
Biol Reprod; 2000 Sep; 63(3):789-96. PubMed ID: 10952922
[TBL] [Abstract][Full Text] [Related]
25. Involvement of transforming growth factor alpha (TGFalpha) and epidermal growth factor receptor (EGFR) in sex hormone-induced prostatic dysplasia and the growth of an androgen-independent transplantable carcinoma of the prostate.
Kaplan PJ; Leav I; Greenwood J; Kwan PW; Ho SM
Carcinogenesis; 1996 Dec; 17(12):2571-9. PubMed ID: 9006091
[TBL] [Abstract][Full Text] [Related]
26. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
Nesterova M; Cho-Chung YS
Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926
[TBL] [Abstract][Full Text] [Related]
27. Retroviral vector-mediated overexpression of the RII beta subunit of the cAMP-dependent protein kinase induces differentiation in human leukemia cells and reverts the transformed phenotype of mouse fibroblasts.
Tortora G; Budillon A; Yokozaki H; Clair T; Pepe S; Merlo G; Rohlff C; Cho-Chung YS
Cell Growth Differ; 1994 Jul; 5(7):753-9. PubMed ID: 7947390
[TBL] [Abstract][Full Text] [Related]
28. Combined blockade of protein kinase A and bcl-2 by antisense strategy induces apoptosis and inhibits tumor growth and angiogenesis.
Tortora G; Caputo R; Damiano V; Bianco R; Fontanini G; Cuccato S; De Placido S; Bianco AR; Ciardiello F
Clin Cancer Res; 2001 Aug; 7(8):2537-44. PubMed ID: 11489837
[TBL] [Abstract][Full Text] [Related]
29. 8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo.
Carlson CC; Chinery R; Burnham LL; Dransfield DT
Neoplasia; 2000; 2(5):441-8. PubMed ID: 11191111
[TBL] [Abstract][Full Text] [Related]
30. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency--involvement of protein kinase A type I.
Holm AM; Aukrust P; Aandahl EM; Müller F; Taskén K; Frøland SS
J Immunol; 2003 Jun; 170(11):5772-7. PubMed ID: 12759461
[TBL] [Abstract][Full Text] [Related]
31. Role of epidermal-growth-factor receptor in tumor progression in transformed human mammary epithelial cells.
Ma L; Gauvillé C; Berthois Y; Degeorges A; Millot G; Martin PM; Calvo F
Int J Cancer; 1998 Sep; 78(1):112-9. PubMed ID: 9724102
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effects of retinoic acid and 8-chloro-adenosine 3',5'-cyclic monophosphate on the regulation of retinoic acid receptor beta and apoptosis: involvement of mitochondria.
Srivastava RK; Srivastava AR; Cho-Chung YS; Longo DL
Clin Cancer Res; 1999 Jul; 5(7):1892-904. PubMed ID: 10430097
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor-alpha short-circuits downregulation of the epidermal growth factor receptor.
Ouyang X; Gulliford T; Huang G; Epstein RJ
J Cell Physiol; 1999 Apr; 179(1):52-7. PubMed ID: 10082132
[TBL] [Abstract][Full Text] [Related]
34. Abrogation of cisplatin-induced programmed cell death in human breast cancer cells by epidermal growth factor antisense RNA.
Dixit M; Yang JL; Poirier MC; Price JO; Andrews PA; Arteaga CL
J Natl Cancer Inst; 1997 Mar; 89(5):365-73. PubMed ID: 9060958
[TBL] [Abstract][Full Text] [Related]
35. Anti-sense suppression of epidermal growth factor receptor expression alters cellular proliferation, cell-adhesion and tumorigenicity in ovarian cancer cells.
Alper O; De Santis ML; Stromberg K; Hacker NF; Cho-Chung YS; Salomon DS
Int J Cancer; 2000 Nov; 88(4):566-74. PubMed ID: 11058872
[TBL] [Abstract][Full Text] [Related]
36. Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A.
Ciardiello F; Caputo R; Pomatico G; De Laurentiis M; De Placido S; Bianco AR; Tortora G
Int J Cancer; 2000 Mar; 85(5):710-5. PubMed ID: 10699953
[TBL] [Abstract][Full Text] [Related]
37. Reversal of resistance to adriamycin by 8-chloro-cyclic AMP in adriamycin-resistant HL-60 leukemia cells is associated with reduction of type I cyclic AMP-dependent protein kinase and cyclic AMP response element-binding protein DNA-binding activities.
Rohlff C; Safa B; Rahman A; Cho-Chung YS; Klecker RW; Glazer RI
Mol Pharmacol; 1993 Mar; 43(3):372-9. PubMed ID: 8383802
[TBL] [Abstract][Full Text] [Related]
38. Cyclic AMP-dependent protein kinase type I is involved in hypersensitivity of human breast cells to topoisomerase II inhibitors.
Tortora G; Ciardiello F; Damiano V; Pepe S; Bianco C; di Isernia G; Davies SL; North P; Harris AL; Hickson ID
Clin Cancer Res; 1995 Jan; 1(1):49-56. PubMed ID: 9815886
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor (EGFR) antisense transfection reduces the expression of EGFR and suppresses the malignant phenotype of a human ovarian cancer cell line.
Brader KR; Wolf JK; Chakrabarty S; Price JE
Oncol Rep; 1998; 5(5):1269-74. PubMed ID: 9683849
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of mdr-1 expression by 8-Cl-cAMP in multidrug resistant MCF-7 human breast cancer cells.
Scala S; Budillon A; Zhan Z; Cho-Chung YS; Jefferson J; Tsokos M; Bates SE
J Clin Invest; 1995 Aug; 96(2):1026-34. PubMed ID: 7543490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
